2025 Annual Meeting | C38 - Case Studies: Challenges in Stroke Treatment and Prevention
Program Materials Program Evaluations
05:00 PM - 05:05 PM PDT | Speaker |
Introduction
Larry B. Goldstein, MD, FAHA, FAAN |
05:05 PM - 05:40 PM PDT | Speaker |
Case Discussions
Larry B. Goldstein, MD, FAHA, FAAN |
05:40 PM - 06:15 PM PDT | Speaker |
Case Discussions
Kara J. Swafford, MD |
06:15 PM - 06:50 PM PDT | Speaker |
Case Discussions
Lawrence R. Wechsler, MD, FAAN |
06:50 PM - 07:00 PM PDT | Q&A |
Questions and Answers
Larry B. Goldstein, MD, FAHA, FAAN, Kara J. Swafford, MD, Lawrence R. Wechsler, MD, FAAN |
Larry B. Goldstein, MD, FAHA, FAAN | The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care. |
Kara J. Swafford, MD | Dr. Swafford has nothing to disclose. |
Lawrence R. Wechsler, MD, FAAN | Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices. |